Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
---|---|---|---|---|---|---|---|---|
KRYS | KRYSTAL BIOTECH INC | United States | $4.56B | 28,292,616 | 75.55% | 24.45% | Net Selling | Net Selling |
TGTX | TG THERAPEUTICS INC | United States | $2.50B | 154,420,772 | 53.78% | 46.22% | Net Selling | Net Selling |
SRPT | SAREPTA THERAPEUTICS INC | United States | $12.63B | 94,523,766 | 73.88% | 26.12% | Net Buying | Net Selling |
VNDA | VANDA PHARMACEUTICALS INC | United States | $280.78M | 57,537,499 | 56.23% | 43.77% | Net Selling | Net Selling |
CORT | CORCEPT THERAPEUTICS INC | United States | $2.55B | 104,112,088 | 30.65% | 69.35% | Net Buying | Net Buying |
GMAB | GENMAB A | Denmark | $19.65B | 66,122,964 | 70.47% | 0.00% | ||
HRMY | HARMONY BIOSCIENCES HOLDINGS INC | United States | $1.79B | 56,791,861 | 61.03% | 38.97% | Net Selling | Net Selling |
BMRN | BIOMARIN PHARMACEUTICAL INC | United States | $15.65B | 189,879,803 | 97.46% | 1.62% | Net Selling | Net Selling |
HALO | HALOZYME THERAPEUTICS INC | United States | $5.06B | 126,824,800 | 78.21% | 21.79% | Net Selling | Net Selling |
INCY | INCYTE CORP | United States | $12.07B | 224,540,751 | 79.30% | 20.70% | Net Selling | Net Buying |
RPRX | ROYALTY PHARMA PLC | United States | $16.97B | 597,434,791 | 51.02% | 16.51% | Net Selling | Net Buying |
AMLX | AMYLYX PHARMACEUTICALS INC | United States | $137.60M | 67,782,139 | 52.42% | 47.58% | Net Buying | Net Selling |
EXEL | EXELIXIS INC | United States | $6.38B | 291,292,704 | 88.76% | 4.24% | Net Selling | Net Buying |
JAZZ | JAZZ PHARMACEUTICALS PLC | Ireland | $6.93B | 63,039,618 | 26.94% | 73.06% | Net Selling | Net Selling |
TECH | BIO-TECHNE CORP | United States | $12.15B | 157,191,685 | 97.66% | 2.34% | Net Buying | Net Selling |
PBYI | PUMA BIOTECHNOLOGY INC | United States | $234.44M | 48,238,850 | 55.16% | 44.40% | Net Selling | |
BNTX | BIONTECH SE | Germany | $22.04B | 237,725,735 | 17.05% | 0.00% | ||
MDXG | MIMEDX GROUP INC | United States | $1.09B | 147,603,955 | 42.42% | 57.58% | Net Buying | Net Selling |
CPRX | CATALYST PHARMACEUTICALS INC | United States | $1.73B | 117,863,258 | 71.64% | 16.33% | Net Buying | Net Selling |
NVO | NOVO NORDISK A S | Denmark | $554.96B | 4,510,000,000 | 6.84% | 0.00% | ||
REGN | REGENERON PHARMACEUTICALS INC | United States | $105.45B | 110,185,503 | 69.34% | 30.66% | Net Selling | Net Buying |
UTHR | UNITED THERAPEUTICS CORP | United States | $11.64B | 44,355,694 | 87.59% | 12.41% | Net Selling | Net Selling |
VRTX | VERTEX PHARMACEUTICALS INC | United States | $103.60B | 258,307,816 | 90.91% | 1.48% | Net Selling | Net Selling |